Neoadjuvant Pembrolizumab in Patients With Stage IIb/c Melanoma

NCT07349303 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER_GOV

Sponsor class

Conditions

Melanoma (Skin Cancer)

Interventions

DRUG: Pembrolizumab
DRUG: Placebo

Sponsor

Vastra Gotaland Region